REFERENCES
1. Reinelt P, Karth GD, Geppert A, Heinz G. Incidence and type of
cardiac arrhythmias in critically ill patients: a single center
experience in a medical-cardiological ICU. Intensive Care Med.
2001;27:1466-73.
2. Tjong FVY, de Ruijter UW, Beurskens NEG, Knops RE. A comprehensive
scoping review on transvenous temporary pacing therapy. Neth Heart J.
2019;27:462-73.
3. Reddy VY, Exner DV, Cantillon DJ, et al. Percutaneous Implantation of
an Entirely Intracardiac Leadless Pacemaker. N Engl J Med.
2015;373:1125-35.
4. Reynolds D, Duray GZ, Omar R, et al. A Leadless Intracardiac
Transcatheter Pacing System. N Engl J Med. 2016;374:533-41.
5. Kypta A, Blessberger H, Kammler J, et al. Leadless Cardiac Pacemaker
Implantation After Lead Extraction in Patients With Severe Device
Infection. J Cardiovasc Electrophysiol. 2016;27:1067-71.
6. El-Chami MF, Johansen JB, Zaidi A, et al. Leadless pacemaker implant
in patients with pre-existing infections: Results from the Micra
postapproval registry. J Cardiovasc Electrophysiol. 2019;30:569-74.
7. Bhadauria D, Chellappan A, Gurjar M, Kaul A, Sharma RK, Prasad N. The
”dilemma of double lifelines”: central venous catheter co-existence with
transvenous cardiac pacemaker. J Vasc Access. 2017;18:e3-5.
8. Roig IL, Darouiche RO, Musher DM, Trautner BW. Device-related
infective endocarditis, with special consideration of implanted
intravascular and cardiac devices in a predominantly male population.
Scand J Infect Dis. 2012;44:753-60.
9. Marik PE, Flemmer M, Harrison W. The risk of catheter-related
bloodstream infection with femoral venous catheters as compared to
subclavian and internal jugular venous catheters: a systematic review of
the literature and meta-analysis. Crit Care Med. 2012;40:2479-85.
10. Fayssoil A, Lazarus A, Wahbi K, et al. Cardiac implantable
electronic devices in tracheotomized muscular dystrophy patients: Safety
and risks. Int J Cardiol. 2016;222:975-7.
11. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac
implantable electronic device infection: a systematic review and
meta-analysis. Europace. 2015;1:767-77.
12. Sodeck GH, Domanovits H, Meron G, et al. Compromising bradycardia:
management in the emergency department. Resuscitation. 2007;73:96-102.
13. Ng ACC, Lau JK, Chow V, Adikari D, Brieger D, Kritharides L.
Outcomes of 4838 patients requiring temporary transvenous cardiac
pacing: A statewide cohort study. Int J Cardiol. 2018;271:98-104.
14. Metkus TS, Schulman SP, Marine JE, Eid SM. Complications and
Outcomes of Temporary Transvenous Pacing: An Analysis of
> 360,000 Patients From the National Inpatient Sample.
Chest. 2019;155:749-57.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of
classifying prognostic comorbidity in longitudinal studies: development
and validation. J Chronic Dis. 1987;40:373-83.
16. Stavem K, Hoel H, Skjaker SA, Haagensen R. Charlson comorbidity
index derived from chart review or administrative data: agreement and
prediction of mortality in intensive care patients. Clin Epidemiol.
2017;9:311-320.
17. Christensen S, Johansen MB, Christiansen CF, Jensen R, Lemeshow S.
Comparison of Charlson comorbidity index with SAPS and APACHE scores for
prediction of mortality following intensive care. Clin Epidemiol.
2011;3:203-11.
18. El-Chami MF, Clementy N, Garweg C, et al. Leadless Pacemaker
Implantation in Hemodialysis Patients: Experience With the Micra
Transcatheter Pacemaker. JACC Clin Electrophysiol. 2019;5:162-70.
19. Roberts PR, Clementy N, Al Samadi F, et al. A leadless pacemaker in
the real-world setting: The Micra Transcatheter Pacing System
Post-Approval Registry. Heart Rhythm. 2017;14:1375-9.
20. Zei PC, Eckart RE, Epstein LM. Modified temporary cardiac pacing
using transvenous active fixation leads and external re-sterilized pulse
generators. J Am Coll Cardiol. 2006;47:1487-9.
21. Chinitz L, Ritter P, Khelae SK, et al. Accelerometer-based
atrioventricular synchronous pacing with a ventricular leadless
pacemaker: Results from the Micra atrioventricular feasibility studies.
Heart Rhythm. 2018;15:1363-71.